News & Perspective

Sep 22, 2017

Sep 22, 2017

News Scan for Sep 22, 2017

MERS in UAE
Vaccine-related polio
More chikungunya in France, Italy
Waning flu vaccine protection
H5N8 in South Africa

May 03, 2016

May 03, 2016

Flu Scan for May 03, 2016

Maternal flu vaccine benefits
H9 case in Egypt
H7N7 outbreak in Italy
Foie gras ban in France

Sep 13, 2013

Sep 13, 2013

Flu Scan for Sep 13, 2013

Global, US flu updates
Three Italian H7N7 cases
Gauging flu vaccine effectiveness
Flu vaccination & neurologic conditions

Sep 03, 2013

Sep 03, 2013

News Scan for Sep 03, 2013

MERS patients' recovery
H7N7 case in Italy
AAP flu vaccine recommendation
Low global flu activity

Feb 03, 2009

Feb 03, 2009

Experts weigh new H5N1 vaccine strategies

(CIDRAP News) – At an Infectious Diseases Society of America (IDSA) symposium in Washington, DC, today on seasonal and pandemic influenza, a group of experts fielded questions from reporters on some of the new trends and emerging issues, including prepandemic strategies for H5N1 avian influenza vaccines, now that some countries are stockpiling them.

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Sep 19, 2006

Sep 19, 2006

Sanofi tests H7N1 flu vaccine for pandemic readiness

(CIDRAP News) – Sanofi Pasteur today announced the start of the first clinical trial of an H7N1 influenza vaccine, intended to guard against the threat of a pandemic caused by H7 strains of avian influenza.

Current concern about a flu pandemic focuses mainly on the H5N1 avian flu virus, which has infected at least 247 people and killed 144. But H7 avian flu viruses have caused a number of mild illness cases and one death in the past 3 years.

Oct 28, 2005

Oct 28, 2005

Chiron wins H5N1 vaccine contract; WHO says virus is changing

(CIDRAP News) – The US government has awarded Chiron Corp. a $62.5 million contract to make a vaccine for H5N1 avian influenza as part of efforts to prepare for a possible human flu pandemic.

Pages

Sort Results By:

 Sort Results By:

Narrow results by:

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»